202657-32-7

Basic information

• Product Name: 6-O-Benzyl-3-O-triethylsilylglucal
• Synonyms: 6-O-Benzyl-3-O-triethylsilylglucal
• CAS NO: 202657-32-7
• Molecular Weight: 350.53
• Mol File: 202657-32-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 6-O-Benzyl-3-O-triethylsilylglucal(CAS DataBase Reference)
• NIST Chemistry Reference: 6-O-Benzyl-3-O-triethylsilylglucal(202657-32-7)
• EPA Substance Registry System: 6-O-Benzyl-3-O-triethylsilylglucal(202657-32-7)

Safety Data

• Hazardous Substances Data: 202657-32-7(Hazardous Substances Data)

Upstream product

• 994-30-9 triethylsilyl chloride 
• 165524-85-6 6-O-(benzyl)-D-glucal 
• 13265-84-4 D-glucal 
• 100-39-0 benzyl bromide 

Downstream Products

• 202657-33-8 (3aS,4R,6S,7R,7aR)-4-Benzyloxymethyl-6-((2R,3R,4R)-2-benzyloxymethyl-4-triethylsilanyloxy-3,4-dihydro-2H-pyran-3-yloxy)-7-hydroxy-tetrahydro-[1,3]dioxolo[4,5-c]pyran-2-one 
• 202657-43-0 C₇₁H₈₉NO₂₀SSi 
• 202657-45-2 N-[(2S,3R,4R,5R,6R)-6-Benzyloxymethyl-5-((3aS,4R,6S,7R,7aS)-4-benzyloxymethyl-2-oxo-7-triethylsilanyloxy-tetrahydro-[1,3]dioxolo[4,5-c]pyran-6-yloxy)-2-ethylsulfanyl-4-triethylsilanyloxy-tetrahydro-pyran-3-yl]-benzenesulfonamide 
• 202657-44-1 N-[(2S,3S,4S,5R,6R)-6-Benzyloxymethyl-5-((3aS,4R,6S,7R,7aS)-4-benzyloxymethyl-2-oxo-7-triethylsilanyloxy-tetrahydro-[1,3]dioxolo[4,5-c]pyran-6-yloxy)-3-iodo-4-triethylsilanyloxy-tetrahydro-pyran-2-yl]-benzenesulfonamide 
• 202657-39-4 Acetic acid (3aS,4R,6S,7R,7aS)-6-((2R,3R,4R,5R,6S)-5-benzenesulfonylamino-2-benzyloxymethyl-6-ethylsulfanyl-4-triethylsilanyloxy-tetrahydro-pyran-3-yloxy)-4-benzyloxymethyl-2-oxo-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yl ester 
• 202657-38-3 Acetic acid (3aS,4R,6S,7R,7aS)-6-((2R,3R,4S,5S,6S)-6-benzenesulfonylamino-2-benzyloxymethyl-5-iodo-4-triethylsilanyloxy-tetrahydro-pyran-3-yloxy)-4-benzyloxymethyl-2-oxo-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yl ester 
• 202657-34-9 Acetic acid (3aS,4R,6S,7R,7aS)-4-benzyloxymethyl-6-((2R,3R,4R)-2-benzyloxymethyl-4-triethylsilanyloxy-3,4-dihydro-2H-pyran-3-yloxy)-2-oxo-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yl ester 
• 202657-35-0 (3aS,4R,6S,7R,7aS)-4-Benzyloxymethyl-6-((2R,3R,4R)-2-benzyloxymethyl-4-triethylsilanyloxy-3,4-dihydro-2H-pyran-3-yloxy)-7-triethylsilanyloxy-tetrahydro-[1,3]dioxolo[4,5-c]pyran-2-one 
• 202657-52-1 (2R,3R,4S,5R,6S)-2-Benzyloxymethyl-6-((2R,3R,4R)-2-benzyloxymethyl-4-triethylsilanyloxy-3,4-dihydro-2H-pyran-3-yloxy)-tetrahydro-pyran-3,4,5-triol 
• 202657-40-7 C₇₄H₈₉NO₂₂SSi 

Relevant articles and documents

Colon cancer KH-1 and N3 antigens

The present invention provides processes for the preparation of the KH-1 and N3 antigens, as well as related analgoues thereof, which are useful as anticancer therapeutics. The present invention also provides various intermediates useful in the preparation of KH-1 and N3 and analogues thereof. Additionally, the invention provides various compositions comprising any of the analogues of KH-1 and N3 available through the methods of the invention and pharmaceutical carriers useful in the treatment of subjects suffering from various forms of epithelial cancer.